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In the embryonic forebrain, pioneer axons establish a simple topography of dorsoventral and longitudinal tracts. The cues used by these axons
during the initial formation of the axon scaffold remain largely unknown. We have investigated the axon guidance role of Neogenin, a member of
the immunoglobulin (Ig) superfamily that binds to the chemoattractive ligand Netrin-1, as well as to the chemorepulsive ligand repulsive guidance
molecule (RGMa). Here, we show strong expression of Neogenin and both of its putative ligands in the developing Xenopus forebrain. Neogenin
loss-of-function mutants revealed that this receptor was essential for axon guidance in an early forming dorsoventral brain pathway. Similar mutant
phenotypes were also observed following loss of either RGMa or Netrin-1. Simultaneous partial knock downs of these molecules revealed dosage-
sensitive interactions and confirmed that these receptors and ligands were acting in the same pathway. The results provide the first evidence that
Neogenin acts as an axon guidance molecule in vivo and support a model whereby Neogenin-expressing axons respond to a combination of
attractive and repulsive cues as they navigate their ventral trajectory.
© 2006 Elsevier Inc. All rights reserved.Keywords: Morpholino; Repulsive guidance molecule; Xenopus; Axon guidance; Chemoattraction; ChemorepulsionIntroduction
During the development of the embryonic nervous system,
axons are guided to their targets by a complex milieu of
chemoattractive and chemorepulsive cues (Chisholm and
Tessier-Lavigne, 1999; Tessier-Lavigne and Goodman, 1996).
Membrane receptors transduce context-dependent signals at the
growth cone, allowing axons to respond appropriately to these
environmental cues and to navigate to their correct position in
the developing nervous system. One receptor that may
contribute to this process is Neogenin, a transmembrane protein
that has ∼50% amino acid identity, and identical secondary
structure, to the Netrin-binding axon guidance receptor deleted
in colorectal cancer (DCC) (Keino-Masu et al., 1996; Vielmetter⁎ Corresponding author. Discipline of Anatomy and Developmental Biology,
School of Biomedical Sciences, University of Queensland, Brisbane 4072,
Australia. Fax: +7 33652955.
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doi:10.1016/j.ydbio.2006.06.018et al., 1994). Together, Neogenin and DCC comprise a subgroup
of the immunoglobulin superfamily of receptors, possessing
four immunoglobulin domains, six fibronectin type III domains,
a single transmembrane region and a cytoplasmic tail. Like
DCC, Neogenin binds to Netrins (Keino-Masu et al., 1996;
Wang et al., 1999), and interactions between Neogenin and
Netrins have been implicated both in cell adhesion during
mammary cap gland formation (Srinivasan et al., 2003), as well
as in myogenic differentiation (Kang et al., 2004). However, in
contrast to DCC, there is as yet no evidence that Neogenin
mediates Netrin activity in the nervous system. In fact, no axon
guidance phenotype has yet been reported in the neo−/− mouse
(Leighton et al., 2001) or in Neogenin-deficient zebrafish
embryos (Mawdsley et al., 2004).
Recent in vitro studies have provided some insight into the
potential role of Neogenin in the nervous system (Rajagopalan
et al., 2004). Rajagopalan and colleagues (2004) identified
Neogenin as a high-affinity receptor for one member of the
repulsive guidance molecule (RGM) family of GPI-linked
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nervous system may be the transduction of RGM signals at the
growth cone. RGM protein was first purified from the posterior
part of the optic tectum in chick and repels temporal retinal
axons in vitro, suggesting that it may be involved in guiding
retinal axons to their correct topographic position in the chick
tectum (Monnier et al., 2002). Three mouse orthologues of
chick RGM (c-RGM) have since been described: RGMa,
RGMb and RGMc (Niederkofler et al., 2004; Oldekamp et al.,
2004; Schmidtmer and Engelkamp, 2004), with RGMa having
the highest homology to c-RGM. RGMa and RGMb share
approximately 45% nucleotide identity and are both expressed
in the nervous system, whereas RGMc is expressed primarily in
skeletal muscle (Oldekamp et al., 2004). Like c-RGM, mouse
RGMa has been implicated in axon guidance. Stripe assay and
co-culture experiments suggest that RGMa is involved in the
establishment of laminae in the developing dentate gyrus
(Brinks et al., 2004). The in vitro evidence provided by
Rajagopalan and colleagues (2004) suggests that a chemo-
repulsive response to RGMa is mediated by Neogenin, and
furthermore that these molecules may function as a ligand/
receptor pair during development. However, a direct in vivo role
for RGMa in axon guidance is yet to be demonstrated.
In the present study, we used the embryonic forebrain of
Xenopus as an in vivo model for assessing the role of Neogenin
in axon guidance. One of the distinct advantages of this system
is that transient loss-of-function approaches can be used to
rapidly assess gene function in situ. By stage 32 (40 h post-
fertilization (hpf)), Xenopus forebrain axons have established a
simple, stereotypical scaffold of tracts, the anatomy of which we
have previously described in detail (Anderson and Key, 1996;
Anderson and Key, 1999; Connor and Key, 2002). Briefly, each
hemisphere of the bilaterally symmetrical axon scaffold consists
of a principal longitudinal tract connected to three dorsoventral
tracts. The tracts arise from neurons located in four main nuclei
and are interhemispherically connected by four commissures
(Figs. 1A and B). We have previously described a unique
glycoform of the neural cell adhesion molecule (N-CAM),
referred to as NOC-2 (Anderson and Key, 1999). NOC-2 isFig. 1. The scaffold of axon tracts in the embryonic Xenopus forebrain. (A) The ma
represented schematically to show the bilateral symmetry of the axon scaffold. The ro
surface of the diencephalon contains the epiphysis (epi). For abbreviations, see belo
subpopulation of axons (red) and acetylated α-tubulin to show all axons (blue). Axo
representation of the trajectory of the NOC-2+ subpopulation of axons in one half o
axons in each brain hemisphere arise in the nPTand course within the AC, POC, SOT,
post-optic commissure; nPT, nucleus of the presumptive telencephalon; nTPOC, nucl
of the post-optic commissure; DVDT, dorsoventral diencephalic tract; epi, epiph
commissure; TPC, tract of the posterior commissure; VC, ventral commissure; VLTexpressed by a subset of neurons in the presumptive nucleus of
the telencephalon (nPT), which contributes axons to the
ventrally directed supraoptic tract (SOT) and the longitudinally
directed tract of the post-optic commissure (TPOC) (Figs. 1B
and C). By perturbing gene expression and subsequently
examining the trajectory of these axons, we show for the first
time that Neogenin acts as an axon guidance receptor in vivo
and is crucial for the correct formation of the early axon scaffold
in the Xenopus brain. Our results are consistent with the
hypothesis that Neogenin mediates signaling through interac-
tions with both RGMa and Netrin-1.Materials and methods
Animals
Embryonic Xenopus laevis borealis were obtained and reared as previously
described (Connor and Key, 2002). Embryos were staged according to
Nieuwkoop and Faber (1956).
Cloning of Xenopus Neogenin orthologue
We used the SMART RACE cDNA amplification kit (Clontech Laboratories
Inc, Palo Alto, CA) and performed 5′- and 3′-RACE using cDNA synthesized
from stages 28 to 37 Xenopus total RNA. Primers were designed against
conserved sequences using a X. laevis laevis EST clone (GenBank accession no.
BI443695). The primer for 5′-RACE was 5′-GACCCATGCCCTTAGAGTTT-
CTTGCC, and for 3′-RACE was 5′-TGAGCAAGGAAGGAAAACCTCG-
CACC. The RACE fragments were sequenced by the Australian Genome
Research Facility (AGRF, Brisbane, Australia) and analyzed using the BLAST
algorithm and ORF Finder at the National Centre for Biotechnology Information
(http://www.ncbi.nlm.nih.gov/BLAST/) to identify the transcriptional start and
termination sites. Primers were designed against these regions to amplify three
full-length ∼4.3 kb clones of Neogenin. The primers used were 5′-AGT-
GAAAAGGTGTGGGATGG and 5′-TTCTTCTCATGCTGGGGTTATGGC.
Two alternative isoforms of the full-length cDNA sequence have been submitted
to GenBank (GenBank accession nos. DQ173197 and DQ173198).
In situ hybridization
The 3.1-kb 5′-RACE fragment of XenopusNeogenin was subcloned into the
pGem-T vector (Promega Corp, Madison WI) and the construct linearized withjor axon tracts and nuclei of the Xenopus forebrain at 40 h post-fertilization are
stral end of the neural tube is curved about the cephalic flexure (c.f.). The dorsal
w. (B) Double-immunolabeling of control Xenopus forebrains for the NOC-2+
ns expressing both NOC-2 and acetylated α-tubulin appear pink. (C) Schematic
f the Xenopus forebrain (arrows). This trajectory is bilaterally symmetrical. The
ventral TPOC, VLTand VC. Scale bar = 60 μm. AC, anterior commissure; POC,
eus of the tract of the post-optic commissure; SOT, supraoptic tract; TPOC, tract
ysis; nTPC, nucleus of the tract of the posterior commissure, PC, posterior
, ventral longitudinal tract.
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probes, respectively. For RGMa probes, we used degenerate primers and nested
5′-RACE to amplify a 0.9-kb product from Xenopus cDNA that we subcloned
into the pGem-TEasy vector (Promega). The primers used (for primary and
nested 5′-RACE, respectively) were 5′-TCCAC(G/A/T)GC(A/G)TT(G/T/C)AC
(A/T/C)ACCTCCTC(G/T/C)GGCAT and 5′-GCCTGGATCTC(A/C/G)A(C/T)
GTGCTG(G/T/C)CC(A/C/G/T)G. Twelve independent clones were sequenced
(AGRF) and found to be identical. These clones were shown to correspond to a
fragment of Xenopus borealis RGMa, by comparison to published sequences for
Xenopus laevis and Xenopus tropicalis RGMa and RGMb (GenBank accession
nos. BC045008, BC061329 and BC061325). The cDNA construct was
linearized with SacII or SpeI in preparation for transcription with sense or
antisense RNA probes, respectively. For Xenopus Netrin-1 probes, we used a
construct provided by Christine Holt and previously published by de la Torre
and colleagues (1997). Digoxigenin (DIG)-labeled probes were synthesized
from the T7 and SP6 polymerase transcription initiation sites by usingiboprobe
In Vitro Transcription Kit (Promega). Manufacturer's instructions were followed
with the exception that we replaced 0.5 μl of unlabelled UTP with 0.5 μl of DIG-
11-UTP (Roche Ltd., Basel, Switzerland). Probes were hydrolyzed to ∼150 bp
as described by (Cox and colleagues 1984) and denatured prior to hybridization
by heating at 70°C for 5 min. Embryos were collected and fixed in 4%
paraformaldehyde (PFA) at stages 31–33 and stored at −20°C in 100%
methanol. Pigment was removed by treating embryos with 0.5% standard saline
citrate (SSC), 10% H2O2, 5% formamide on a light box for 5–10 min. In situ
hybridization, probe detection and NOC-2 immunohistochemistry were carried
out using standard protocols as previously described (Connor and Key, 2002).
Morpholinos
To determine the 5′UTR and transcription initiation site for our genes of
interest, we sequenced 5′-RACE fragments obtained as described above for
Neogenin and RGMa (Clontech). The gene-specific primers for Netrin-1 (for
primary and nested 5′-RACE, respectively) were 5′-ACCGTGAACTTCCAC-
CAGTCTCCTGCC and 5′-GCTTCTCGTGCTGTTGCTCTCTGCC. 5′-RACE
was also performed to determine the 5′UTR for an unrelated ligand, Semaphorin
3. The gene-specific primer used was 5′-TTGCCCCAACATAAAGTCTTCCC-
CGTT. Products were cloned into the pGem-TEasy vector (Promega) and
sequenced by the Australian Genome Research Facility. Where necessary, the
open reading frame was identified using the NCBI BLAST algorithm and ORF
Finder analysis tool (http://www.ncbi.nlm.nih.gov).
The morpholinos (MOs) were designed and provided by GeneTools, LLC
(Philomath, USA). For each mRNA sequence, we used two non-overlapping
MOs:
Neo-ATG: 5′-GACTTCGGACTGCCATCCCACACCT;
Neo-UTR: 5′-CACTGCGACCCACTCTTCACCATCC;
RGM-ATG: 5′-CATCCATCCAGCTTGGGCTTTAACC;
RGM-UTR: 5′-CTCACCCTGGACGAACAGTTAAGAG;
Netrin-ATG: 5′-GAAGACCAACTGACACCTCAGCATC; and
Netrin-UTR: 5′-GAAGATCACCTTAACCCAGCCTTGG.
We also used the Standard Control MO provided by GeneTools (Std Control
MO; a scrambled 25-mer), and an MO designed against an unrelated ligand,
Semaphorin 3 (Sema3-ATG MO: 5′-TGCAATCCAGGTCAGAGAGCC-
CATG). MOs were co-injected with EGFP mRNA into one blastomere at the
2- to 4-cell stage, as described below. Each embryo received a total of 11.5 ng of
MO or 5.8 ng of MO for the partial knock down injections.
EGFP reporter constructs
In the absence of antibodies against our genes of interest, we determined the
efficacy of our MO knock downs by generating enhanced green fluorescent
protein (EGFP) reporter constructs. Unique forward primers were designed for
each construct to encode both the ATG and UTR MO target sequences for each
gene, followed immediately by an in-frame sequence encoding EGFP. A
common reverse primer was used to generate all constructs and was designed
against the 3′ region of EGFP, including a stop codon and an engineered XbaIrestriction site. The common reverse primer was 5′-GGTCTAGATTAATTAAT-
TACTTGTACAGCTCGTCCATGCC. The unique forward primers were as
follows: Neo-EGFP: 5′-GGATGGTGAAGAGTGGGTCGCAGTGAAAA-
GGTGTGGGATGGCAGTCCGAAGTCCCATGGTGAGCAAGGGCGAGG;
RGMaEGFP: 5′-CTCTTAACTGTTCGTCCAGGGTGAGGGTTGCGGT-
TAAAGCCCAAGCTGGCTGGATGGTGAGCAAGGGCGAGGAGC and
Netrin-1-EGFP: 5′-CCAAGGCTGGGTTAAGGTGATCTTCAGAAAGATG-
CTGAGGTGTCAGTTGGTCTTCATGGTGAGCAAGGGCGAGG. PCR pro-
ducts were amplified from a pEGFP-1 plasmid (BD Biosciences) in a standard
reaction mixture using PCR Supermix (Invitrogen) and subsequently cloned into
the pGem-TEasy vector (Promega). EGFP fusion constructs were excised from
pGem-TEasy using EcoRI and XbaI and subcloned into the pCS2+ vector.
Purified plasmid for each EGFP fusion/pCS2+ construct was injected into Xe-
nopus blastomeres (as described below), producing mosaic EGFP expression in
all injected embryos (generated from the strong constitutive simian CMV IE94
enhancer/promoter present in pCS2+). The efficacy of our ATG and UTR MOs
for each gene was tested by co-injecting each of the EGFP fusion plasmids with
their corresponding MOs, to extinguish the mosaic expression of EGFP.
RNA synthesis
Dominant-negative Xenopus Neogenin (DN-Neo) containing sp1 was
synthesized by amplifying a ∼3.4-kb region from a Xenopus Neogenin/pCS2+
plasmid that incorporated the transcriptional start site through the transmembrane
domain, with an engineered STOP site located immediately downstream of the
sequence encoding the transmembrane domain. The primers used were forward,
5′-AGTGAAAAGGTGTGGGATGG and reverse, 5′-ATCTCGAGTCAACGG-
GAACATATGGC. We then added an SV40 polyA signal by subcloning into
pCS2+ and finally cloned this fragment into the pGemT-Easy vector (Promega).
This construct was linearized using NsiI in preparation for synthesis of mRNA
under the T7 promoter. Enhanced green fluorescent protein (EGFP) in the
pSP64TK or pCS2+ vector was linearized using XbaI or NotI, respectively.
Capped RNAwas synthesized by in vitro transcription using the mMessage
mMachine SP6 or T7 capped RNATranscription Kits (Ambion Inc), according
to the manufacturer's instructions. Blastomeres were injected at the 1–4 cell
stage as described below using a 1:1 mix of EGFP mRNA (1 mg/ml) and DN-
Neo mRNA (1–2 mg/ml). Control embryos were injected with EGFP mRNA
alone such that the same total amount of mRNA was delivered to both control
and experimental animals.
Microinjection of Xenopus blastomeres
Fertilized X. laevis borealis eggs were prepared and microinjected at the
1–4 cell stage as described by Connor and Key (2002). Blastomeres were
injected with 4.6 nl of a 1:1 mix of either morpholino or DN-Neo mRNA and
EGFP mRNA. Three control groups were used for each batch of eggs to
control for variables such as egg quality, needle diameter and stage and
temperature of development: needle stab controls were pierced with the needle
without injection; mRNA controls were injected with EGFP mRNA alone; and
morpholino controls were injected with a mix of Std Control MO and EGFP
mRNA so that the same total amount of mRNA and MO was delivered to
both control and experimental animals. Injected animals were fixed at stage 32
in 4% PFA. All experiments were repeated at least three times for each
condition.
Immunohistochemistry and analysis
Whole brains of fixed stage 32 embryos from all control and experimental
groups were immunolabeled for NOC-2 (to label a subpopulation of axons) and
acetylated α-tubulin (to label all axons) as previously described (Connor and
Key, 2002). Serial optical sections were collected using a Bio-Rad MRC-1024
laser scanning confocal microscope coupled to a Zeiss Axioplan microscope.
Scans were compiled, color balanced and oriented using Adobe Photoshop 7.0
software, without further digital manipulation. For each animal in all
experimental and control groups, we independently assessed both forebrain
hemispheres, initially screening for EGFP as a marker for injected hemispheres,
then for axon guidance defects. Phenotype data were collected from at least 15
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experimental condition. Using a Chi-square test of association, we observed no
statistically significant differences between any repeats of the same condition.
Therefore, the final analysis of phenotypes was performed by pooling the data
from the three repeats of each condition. We found no statistically significant
difference between any of our control conditions (needle stab, EGFP mRNA
only or Std Control MO co-injected with EGFP mRNA). Subsequently, the
phenotypes in the DN-Neo mRNA group were compared to EGFP mRNA
controls, and all single MO-injected animals were compared to the appropriate
Std Control/EGFP-injected group. Phenotype numbers in the simultaneous
partial knock down groups were compared with single injections of each MO
alone, at the reduced levels. Variables such as egg quality, needle diameter and
stage/temperature of development had some influence on the phenotype countsFig. 2. Neogenin mRNA is expressed in the developing Xenopus forebrain. (A) T
Neogenin contains an open reading frame of 4326 bp and encodes a protein of 1442 am
(FnIII) domains, a transmembrane region (TM) and a cytoplasmic tail containing thre
exons are indicated (splice 1, bp 1273–1332; splice 2, bp 2534–2581; splice 3, bp 36
stop codon, resulting in a truncated protein. Xenopus Neogenin possesses an SQTG a
motif for caspase-3 cleavage, suggesting that Neogenin is unlikely to be involved
antisense probe is identified. (B) Lateral view of NeogeninmRNA expression on a wh
Neogenin expression is predominant in the head (asterisk) and spinal cord (arrowhead
expression in isolated CNS tissue from a stage 30–31 Xenopus embryo. The forebrai
midbrain–hindbrain boundary (MHB) are indicated. Neogenin expression (indicated
midbrain. Expression is also strong in the ventral hindbrain. Neogenin is absent f
boundary and dorsal hindbrain. (D) Dorsorostral view of an isolated stage 30–31 X
expression of Neogenin extending from both sides of the midline to the lateral margin
of Neogenin expression is indicated (hatched circles), based on double-labeling expe
double-labeled for Neogenin mRNA expression (blue) and the NOC-2+ subpop
Magnification of a region of the forebrain in lateral view, equivalent to that indicated b
which appears deep purple in this double label). Neogenin is expressed in the nucleus
neuroepithelium underlying the supraoptic tract (SOT) and the longitudinally oriente
indicated. (F) Dorsorostral view of a double-labeled brain, showing that Neogenin is
forebrain, and the epiphysis (e) is indicated at the dorsal surface of the brain. (G) S
scaffold in the Xenopus forebrain. Scale bar in panel B=500 μm, panels C–F=60 μbetween experiments performed on different days; however, within the different
experiments the results were robust and statistically significant.
Results
Neogenin is expressed in the Xenopus forebrain
A PCR-based strategy was used to identify and clone Xe-
nopus Neogenin (Fig. 2A). The full-length coding region of
Xenopus Neogenin (GenBank accession no. DQ173198) was
obtained and shown to have identical secondary structure to allhe predicted structure of Xenopus Neogenin is shown schematically. Xenopus
ino acids. It has four immunoglobulin-like (Ig) domains, six fibronectin type III
e highly conserved domains (P1–P3). The positions of three alternatively spliced
53–3680). The inclusion of splice 3 (28 bp) imparts a frameshift and premature
mino acid motif in its cytoplasmic tail, instead of the usual conserved C(C/T)TD
in caspase-3-mediated cell death in Xenopus. The region used for synthesis of
ole-mount stage 30–31 Xenopus embryo, dorsal to the top and rostral to the left.
) and is also present in the gut and somites. (C) Lateral view of NeogeninmRNA
n (fb), midbrain (mb), hindbrain (hb), forebrain–midbrain boundary (FMB) and
by the dashed line) is strong in the dorsal forebrain and extends into the ventral
rom the hypothalamus (h), epiphysis (e) dorsal midbrain, midbrain–hindbrain
enopus brain, dorsal to the top (indicated by the epiphysis (e)), showing strong
s of the dorsal forebrain. The estimated position of the nPT relative to these zones
riments (see panel F). (E–F) Isolated CNS from stage 30–31 Xenopus embryos,
ulation of forebrain axons (brown), revealing their spatial relationship. (E)
y a box in panel C, double-labeled for Neogenin (blue) and NOC-2 (brown stain,
of the presumptive telencephalon (nPT, indicated by the dashed circle) and in the
d tract of the post-optic commissure (TPOC). The anterior commissure (AC) is
expressed by the nPT (arrows). The AC is indicated at the rostral margin of the
chematic representation of Neogenin mRNA expression in relation to the axon
m.
Fig. 3. Morpholino controls demonstrate efficacy of targeted knock down
approach. Bright-field and fluorescent image analysis of stage 30–32 Xenopus
embryos co-injected with plasmids encoding EGFP reporter constructs and
morpholinos. Rostral is to the left and dorsal to the top in all panels. (A–B)
Embryos injected with 5′Neo-EGFP/pCS2+ alone (230 ng) displayed strong
mosaic expression of EGFP at stage 32 (40 hpf). (C–D) Embryos co-injected
with an equivalent amount of 5′Neo-EGFP/pCS2+ and Neo-ATG MO (11.5 ng)
failed to express EGFP. Embryos co-injected with the EGFP reporter plasmid
and Neo-UTRMO had the same appearance. (E–F) Embryos co-injected with 5′
Neo-EGFP/pCS2+ and a control nonsense MO (Std Control MO, 11.5 ng)
showed strong mosaic EGFP expression. (G–H) Co-injection of 5′Neo-EGFP/
pCS2+ with a morpholino targeted to an unrelated gene in Xenopus
(Semaphorin3; Sema3-ATG MO, 11.5 ng) also produced embryos with strong
mosaic expression of EGFP. Scale bar=1 mm.
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acid identity to chick Neogenin (Vielmetter et al., 1994).
Whole-mount in situ hybridization on stage 30–31 embryos
(36–38 hpf) revealed that Neogenin was prominently expressed
in the embryonic head (Fig. 2B). When the brains were
dissected from these animals, Neogenin was clearly shown to be
present in the neuroepithelium of the forebrain, ventral midbrain
and hindbrain, whereas it was absent from the developing
hypothalamus, dorsal midbrain, epiphysis and midbrain–
hindbrain boundary (Figs. 2C and D). Double staining of the
in situ labeled brains with antibodies against the NOC-2+
subpopulation of forebrain axons revealed that Neogenin was
expressed by the nPT neurons that gave rise to these axons
(Figs. 2E and F).
Loss of Neogenin function causes axon pathfinding errors in
the supraoptic tract
To assess the role of Neogenin in the developing Xenopus
forebrain, we used two distinct loss-of-function approaches.
First, antisense morpholinos (MOs) knocked down expression
of Neogenin; and second, overexpression of a dominant-
negative form of Neogenin was used to disrupt transmembrane
signaling by this receptor. Both approaches gave similar
phenotypes (see below), which confirmed the specificity of
these two strategies. In addition, we used two distinct antisense
oligonucleotide MOs targeted against non-overlapping regions
of Neogenin mRNA transcripts to knock down expression of
Neogenin. The first MO was designed to target the region
encompassing the ATG start site (Neo-ATG MO) and the
second was designed to target the 5′UTR (Neo-UTR MO). As a
control, we used a random non-specific 25-mer MO (Std
Control MO). Because MOs selectively bind to the mRNA of
interest and sterically inhibit translation without degradation of
the mRNA, in situ hybridization cannot be used to determine
the effectiveness of the knock downs (Heasman, 2002).
Therefore, as a test of the efficacy of our MOs, we generated
an enhanced green fluorescent protein (EGFP) reporter
construct (Neo-EGFP/pCS2+) that contained the 5′UTR and
ATG sequences of Xenopus Neogenin, upstream of EGFP.
This reporter plasmid contained a strong, constitutive CMV
promoter/enhancer, which produced mosaic expression of
EGFP in developing embryos following blastomere injection
at the 1–2 cell stage (Figs. 3A and B). We expected the
translation of this construct (and hence EGFP expression) to be
knocked down upon co-injection with either of the two
Neogenin MOs, yet unaffected by co-injection with the
nonsense Std Control MO, or by any other MO targeted to an
unrelated gene. In contrast to the fluorescence displayed by
embryos injected with Neo-EGFP/pCS2+ alone, all embryos
co-injected with Neo-ATG MO and Neo-EGFP/pCS2+ lacked
EGFP fluorescence (Figs. 3C and D), indicating that Neo-ATG
MO was highly effective in blocking translation, even 40 h after
its injection into blastomeres. Similar results were obtained
when Neo-UTR MO and Neo-EGFP/pCS2+ were co-injected
(data not shown). As expected, the scrambled Std Control MO,
and an MO targeted to an unrelated gene (Semaphorin3; Sema3-ATGMO) had no effect on translation of the Neo-EGFP/pCS2+
reporter construct (Figs. 3E–H).
Having established that our Neogenin MOs were effectively
blocking translation, we next injected them into Xenopus
blastomeres to determine the role of Neogenin in the developing
forebrain. Axon guidance defects were assessed by examining
the trajectory of the NOC-2+ subpopulation of axons. In
addition, the development of the whole scaffold of the axon
tracts in the brain was examined by co-labeling with the pan-
neuronal antibody directed against α-acetylated tubulin (see
Fig. 1B). This approach enabled us to verify that forebrain
490 N.H. Wilson, B. Key / Developmental Biology 296 (2006) 485–498patterning and neuronal development was not grossly disturbed
in our experimental animals. Each MO was co-injected with
EGFP mRNA (which was used to trace injected cells) at the 1–4
cell stage, and the animals were allowed to survive until stageFig. 4. Knock down of Neogenin or expression of dominant-negative Neogenin caus
and EGFP mRNA (A–C, J), Neogenin MOs and EGFP mRNA (D–I), (K–L) or dom
of dissected brains from stage 32 embryos, immunolabeled for the NOC-2+ subpopul
left in all panels. (A–C) Injection of the Std Control MO does not affect the trajector
arrowhead), coursing ventrocaudally from the nPT in the dorsal forebrain to the ventra
2 (red) and acetylated α-tubulin (blue) for all axons reveals normal forebrain morp
margins of the dissected brain. (C) Injected cells were traced by EGFP fluorescence
knock down using Neo-ATG or Neo-UTRMOs, as indicated. The SOT is reduced in
H–I are magnified in panels K–L, respectively) and nPT axons are observed to follow
(E–F) The same brain as in panel D, double- or triple-labeled as in panels B and C, to
(J–L) Magnification of the boxed areas in panels A, D and I, respectively, to show the
Neogenin either prevented some nPT axons from growing ventrally within the SOT (
comprised of a single axon) or caused them to grow along abnormal longitudina
representation of the Neogenin truncation construct (DN-Neo) which lacked the c
encoding DN-Neo and EGFP (N–O). Overexpression of DN-Neo caused defects i
animals. The SOT often failed to develop (arrowhead in panels N–O, compare to pa
scaffold development was grossly normal in these animals. Scale bar=30 μm. Scale b32 (40 hpf). The gross morphology of the whole embryos and
their dissected brains was normal and indistinguishable between
animals injected with either a specific Neogenin or the Std
Control MO (Figs. 4B, C, E, F). The acetylated α-tubulines axon pathfinding errors. Embryos were co-injected with the Std Control MO
inant-negative Neogenin mRNA and EGFP mRNA (N–O). All are lateral views
ation of axons unless otherwise indicated. Dorsal is to the top and rostral is to the
y of the NOC-2+ subpopulation of axons. (A) The SOT appears normal (unfilled
l TPOC. The boxed region is magnified in panel J. (B) Double-labeling for NOC-
hology (compare to Fig. 1B). The dashed line in panels A and B indicates the
(green). (D–I) Four examples of abnormal phenotypes observed after Neogenin
size or fails to form properly (arrowheads in panels D–I, boxed regions in panels
aberrant trajectories in the dorsal forebrain (arrows in panels D–F, H–I, K–L).
show that the axon scaffold in Neogenin MO-injected animals is grossly normal.
SOT phenotype in control (J) and Neogenin knock down animals (K–L). Loss of
arrowheads in panels K–L, unfilled arrowhead in panel K shows a reduced SOT
l trajectories in the dorsal forebrain (arrows in panels K–L). (M) Schematic
ytoplasmic signaling domain. Embryos were injected with mRNA transcripts
n SOT formation, similar to that described for the Neogenin MO knock down
nel G). Co-labeling for acetylated α-tubulin (blue in panel O) showed that axon
ar in panel O applies in panels A–I, N; scale bar in panel L applies in panels J–K.
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overall topography of the neuronal clusters and the trajectory of
the principal axon tracts were normal. In contrast, immuno-
staining for NOC-2+ axons revealed that antisense MO knock
down of Neogenin produced a significant axon guidance
phenotype in the dorsorostral brain (compare Fig. 4Awith Fig.
4D). Defects were selectively observed in the guidance of axons
exiting the nucleus of the presumptive telencephalon (nPT) in
the dorsal forebrain. A subset of axons from this nucleus
typically forms the supraoptic tract (SOT) by coursing
ipsilaterally in a smooth caudoventral trajectory to fasciculate
with axons in the ventral TPOC (Figs. 4A and J). Other nPT
axons course anteriorly, contributing to the anterior commissure
(AC) and post-optic commissure (POC) at the rostral margin of
the forebrain (see Figs. 1A–C). Following Neogenin knock
down with either of our antisense MOs, two significant
abnormalities were identified (Table 1). In ∼35% of brain
hemispheres injected with Neo-ATGMO (n=81), NOC-2+ nPT
axons failed to successfully navigate the SOT and connect the
dorsal to the ventral forebrain. These axons either failed to enter
the SOT pathway, or seemed to stall within the tract (filled
arrowheads, Figs. 4D–I, K, L). In addition to these defects,
∼50% of hemispheres injected with Neo-ATG MO displayed
NOC-2+ axons that inappropriately exited the caudal nPT,
where they projected into the dorsal forebrain. Many of these
axons continued to course longitudinally through the midbrain
before turning ventrally to reach the TPOC (arrows, Figs. 4D–F,
H–I, K–L). The anterior, post-optic and ventral commissures
continued to develop normally in the absence of Neogenin,
indicating that Neogenin was selectively involved in guiding
nPT axons to form the SOT.
Because phenotypes produced by each of the two MOs were
similar (Table 1; compare Fig. 4H with Fig. 4I), it strongly
indicated that both MOs were specifically knocking downTable 1
Knock down of Neogenin, or perturbation of Neogenin signaling, causes axon
guidance defects
Injection regime a n b SOT reduced or
unformed (%)
Aberrant projection
of nPT axons in
dorsal forebrain (%)
Controls
Needle stab 66 12.1 16.6
EGFP mRNA 165 15.7 20.2
Std Control MO 87 21.8 16.1
Neogenin loss-of-function
Neo-ATG MO 81 35.8* 50.6***
Neo-UTR MO 87 35.6* 43.7***
Neo-ATG + Neo-UTR MOc 91 46.2** 49.4***
DN-Neo mRNAd 71 57.7*** 35.2*
*p<0.05, **p<0.001, ***p<0.0001; Chi-square test of association.
a All groups except needle stab controls were co-injected with 2.3 ng of
EGFP mRNA per embryo to trace injected cells. MO-injected groups received a
total of 11.5 ng of MO.
b n refers to the number of injected brain hemispheres examined (identified
by fluorescence of EGFP in all groups except needle stab controls).
c Co-injected with 5.8 ng of each MO.
d Injected with 2.3 ng of DN-Neo mRNA.Neogenin. The specificity of this response was further con-
firmed by a genetic interaction strategy. If the MOs were acting
specifically on Neogenin, then co-injection of reduced amounts
of both MOs should phenocopy an injection of an equivalent
amount of a single MO. Indeed, we revealed that a co-injection
of 5.8 ng of Neo-ATG MO together with 5.8 ng of Neo-UTR
MO produced an identical phenotype to a single 11.5-ng
injection of each MO (Table 1). Taken together with the results
from our EGFP reporter constructs, these co-injection experi-
ments rigorously confirmed both the efficiency and the
specificity of the Neogenin MOs.
Because our MO knock down experiments revealed an axon
guidance role for Neogenin, we next tested the role of Neogenin
transmembrane signaling in this behaviour. We generated an
mRNA construct encoding a truncated form of Neogenin that
lacked the cytoplasmic domain (DN-Neo; Fig. 4M), a region
which has previously been shown to be involved in transmem-
brane signaling (Xie et al., 2006). When overexpressed in Xe-
nopus embryos by blastomere injection, we reasoned that the
mutant Neogenin construct would act as a dominant-negative
and continue to bind its ligands without activating transmem-
brane signaling pathways. A similar mechanism has previously
been demonstrated for the closely related receptor, DCC (Stein et
al., 2001). DN-Neo mRNAwas co-injected with EGFP mRNA
at the 1–4 cell stage, and animals were subsequently analyzed at
stage 32, as described for the antisense MOs. Control animals
were injected with an equivalent amount of EGFP mRNA alone.
As for the MO injection experiments, the gross morphological
development of the embryos injected with DN-Neo proceeded
normally and was identical to those injected with control EGFP.
Forebrain patterning and overall axon tract formation were also
normal, as assessed by immunolabeling for acetylated α-tubulin
(Fig. 4O). However, NOC-2 immunolabeling revealed that
overexpression of DN-Neo (Figs. 4N and O) caused similar
defects in SOT formation and nPT axon guidance to those
observed following Neogenin knock down with MOs (Table 1;
compare Fig. 4N with Fig. 4G). In ∼58% of brain hemispheres
injected with DN-Neo mRNA (n=71), NOC-2+ axons failed to
successfully project along the SOT (Figs. 4N andO). In addition,
∼35% of DN-Neo-injected hemispheres displayed abnormal
nPT axon trajectories within the dorsal forebrain. These results
reinforced the selective role of Neogenin in guiding nPTaxons to
form the SOT. Further, this independent method of perturbing
Neogenin function indicated that signaling through the cyto-
plasmic domain of Neogenin, and not co-receptors, was essential
for the normal development of this tract. Taken together, the
antisense MO and dominant-negative experiments have pro-
vided the first evidence that Neogenin plays an axon guidance
role during in vivo development.
The Neogenin ligands RGMa and Netrin-1 are expressed in the
Xenopus forebrain
The above results indicated that Neogenin, which is
expressed by neurons in the nPT, is involved in mediating the
ventral growth of axons within the SOT. In the absence of this
receptor, or when cytoplasmic signaling by Neogenin is
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take highly aberrant trajectories. To identify possible guidance
cues that may be interacting with Neogenin in this context, we
next examined expression of two putative ligands for Neogenin:Fig. 5. The Neogenin ligands RGMa and Netrin-1 are expressed in the developing Xe
performed on whole-mount stage 30–31 embryos (A, G) and isolated stage 30–31 bra
Combined in situ staining (blue) with immunostaining for the NOC-2+ subset of fore
formation and mRNA expression (D–E, J–K). (A) In lateral view of a whole-mount
and branchial arches (ba). (B) In lateral view of an isolated brain, strong RGMa e
Expression extends rostrally in a band from the dorsal telencephalon, terminating in a
absent from the trajectory of the TPOC (arrowhead) but a patch of expression is dete
throughout the ventral half of the midbrain and hindbrain, extending in dorsal peaks a
(C) In dorsorostral view (epiphysis (e) indicates the dorsal surface of the brain),
neuroepithelium medial to the estimated position of the nPT (hatched circles, com
expression in the forebrain (asterisks) extends laterally. Lateral (D) and dorsorostral
absent from the pathway underlying the nPT, AC and TPOC. The SOT forms along
region in devoid of RGMa (unfilled arrowhead in panel D). (G) In lateral view of a w
(arrow) and throughout the ventral CNS (arrowhead). Expression is also detected in t
throughout the ventral forebrain, midbrain and hindbrain. A distinct patch of express
that Netrin-1 expression in the dorsal forebrain (arrows) is located medially, close to
compare to double-labeled image in panel K). The epiphysis (e) denotes the dorsal
shows that Netrin-1 expression lies medial to the nPT, and underlies the TPOC (arrow
relative to the axon scaffold is consistent with their potential interaction with Neogeni
arrowhead). Scale bar in panel G=500 μm and also applies to panel A, scale bar in
applies to panels C, E, I.RGMa (Matsunaga et al., 2004; Rajagopalan et al., 2004) and
Netrin-1 (Srinivasan et al., 2003).
In whole embryos, RGMa mRNAwas strongly expressed in
the brain, spinal cord and branchial arches (Fig. 5A). When thenopus forebrain. In situ hybridization for RGMa (A–E) and Netrin-1 (G–K) was
ins, indicated by dashed lines (B–C, H–I). All staining is bilaterally symmetrical.
brain axons (brown) was performed to show the relationship between axon tract
Xenopus embryo, RGMa expression is detected in the brain, spinal cord somites
xpression is detected in the forebrain (fb), midbrain (mb) and hindbrain (hb).
ventral ‘wedge’ (asterisk) at the rostral end of the forebrain. RGMa expression is
cted in the ventral forebrain, dorsal to the hypothalamus (h). RGMa is expressed
t the forebrain–midbrain boundary and midbrain–hindbrain boundary (arrows).
RGMa expression in the forebrain is detected along the midline and in the
pare to double-labeled image in panel E). The rostroventral wedge of RGMa
views (E) of brains double-labeled for NOC-2 shows that RGMa expression is
the border of the rostroventral ‘wedge’ of RGMa expression, then grows into a
hole-mount Xenopus embryo, Netrin-1 is detected in a distinct patch in the brain
he ventral retina and the branchial arches (ba). (H) Netrin-1 expression is strong
ion is also present in the dorsal forebrain (arrow). (I) A dorsorostral view shows
the midline. The estimated positions of the nPT are indicated (hatched circles,
surface of the brain. (I) Double-labeling in lateral (J) and dorsorostral view (K)
heads). (F, L) Schematic representations of the expression of RGMa and Netrin-1
n as ligand-receptor pairs in the guidance of nPT axons to form the SOT (unfilled
panel J=60 μm and applies to panels B, D, H, scale bar in panel K=60 μm and
Table 2
Knock down of the Neogenin ligands RGMa and Netrin-1 causes axon guidance
defects
Injection regime a n b SOT
reduced or
unformed (%)
Abnormal nPT
axons in dorsal
forebrain (%)
Midline
crossing failure
in VC (%)
Controls
Needle stab 66 12.1 16.6 0.0
Std Control MO 87 21.8 16.1 0.0 c
RGMa loss-of-function
RGM-ATG MO 100 52.0*** 33.0* 3.0
RGM-UTR MO 82 40.2* 50.0*** 1.2
RGM-ATG +
RGM-UTR MOd
80 38.8* 40.0** 1.3
Netrin-1 loss-of-function
Netrin-ATG MO 72 40.3* 44.4*** 18.1 e
Netrin-UTR MO 92 36.9* 39.1** 16.3 e
Netrin-ATG +
Netrin-UTR MOd
90 47.8** 37.8** 23.3 e
*p<0.05, **p<0.001, ***p<0.0001; Chi-square test of association.
a All embryos except needle stab controls were co-injected with a total of
11.5 ng of MO, and 2.3 ng of EGFP mRNA to trace injected cells.
b n refers to the number of injected brain hemispheres examined (identified
by fluorescence of EGFP in all groups except needle stab controls).
c No statistical analysis was able to be carried out on the VC phenotype for
the MO-injected animals because the value in the Std Control MO group was
equal to zero.
d Co-injected with 5.8 ng of each MO.
e This value is likely to be a conservative estimate because the lateral
orientation of the whole-mount brain preparations used in this analysis was not
ideal for assessing commissural defects at the ventral midline.
Fig. 6. Knock down of either RGMa or Netrin-1 phenocopies the SOT defect
arising from knock down of Neogenin in vivo. All panels show lateral views of
dissected brains from stage 32 embryos, dorsal to the top, rostral to the left,
immunolabeled for the NOC-2+ subpopulation of axons unless otherwise
indicated. Embryos were co-injected with EGFP mRNA and MOs against
RGMa (A–D) or Netrin-1 (E–H). (A, C–D) Three examples of abnormal
phenotypes observed after RGMa knock down. The SOT is reduced (A, C) or
fails to completely project between the nPT and the TPOC (C–D, arrowhead).
The unfilled arrowheads show single axons that have navigated the SOT. Axons
from the nPT project aberrantly in the dorsal forebrain (A, arrows). (B) The same
brain as in panel A, double-labeled for NOC-2 (red) and acetylated α-tubulin
(blue) shows that the axon scaffold is grossly normal. The dashed line indicates
the margins of the brain. (E, G–H) Three examples of abnormal phenotypes
observed after knock down of Netrin-1. The SOT is reduced (H, unfilled
arrowhead) or fails to form (E, G). There are also defects in the formation of the
ventral commissure (F, H, arrows). (F) Magnification of the boxed area in panel
E showing VC defects. Several axons appear to loop back towards the ipsilateral
TPOC (arrows) and fail to cross the midline. The dashed line in panel F indicates
the ventral margin of the brain. For control phenotype, see Fig. 4A. Scale
bar=30 μm; scale bar in panel H applies to panels A–E, G–H.
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be present throughout the ventral half of the midbrain and
hindbrain, extending dorsally in two peaks that demarcated the
midbrain–forebrain and midbrain–hindbrain boundaries
(arrows, Fig. 5B). In the forebrain, RGMa was expressed in
two distinct dorsal and ventral bands. RGMa expression in the
dorsal forebrain extended in a longitudinal stripe, which
appeared to lie ventral to the nPT. This dorsal expression
band had an interesting rostral wedge that curved ventrally
(asterisk, Figs. 5B and C). In the ventral forebrain, RGMa was
detected in a stripe immediately dorsal to the hypothalamus but
was absent from the trajectory of the TPOC (arrowhead, Fig.
5B). Co-labeling for the NOC-2+ subset of axons confirmed that
the nPT neurons projecting into the SOT did not express RGMa.
Moreover, this staining revealed that the SOT axons coursed
along the edge of the rostral wedge of neuroepithelium-
expressing RGMa (unfilled arrowhead, Figs. 5D and F). Thus,
it appeared as though RGMa was acting to funnel axons into the
SOT. Interestingly, the TPOC axons (Fig. 5D) in the ventral
brain coursed through a stripe of neuroepithelium lacking
RGMa, which lay between the rostral wedge and the ventral
band of RGMa expression (arrowhead, Fig. 5B).
As previously reported (de la Torre et al., 1997), strong
Netrin-1 expression was detected ventrally in the brain (Figs.
5G and H) as well as in a distinct dorsal patch in the forebrain,
adjacent to the midline (arrows, Figs. 5G–I). Co-labeling for the
NOC-2+ subset of axons revealed that the ventral stripe ofNetrin-1 expression coincided with the TPOC (arrowheads, Fig.
5J). The nPT neurons were located laterally to the patches of
Netrin-1 expression in the forebrain (Fig. 5K). Schematics of
the distribution of Netrin-1 and RGMa in relation to axon tracts
are shown in Figs. 5F and L. Taken together, the expression
patterns of these ligands are consistent with their presumptive
role in Neogenin-mediated axon guidance in the SOT.
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knock down in vivo
Next, we examined the effect of knocking down RGMa and
Netrin-1 on axon guidance in the forebrain. Two independent,
non-overlapping MOs against RGMa, one targeting the start/
ATG site (RGM-ATG MO) and the other designed against the
5′UTR (RGM-UTR MO) produced similar phenotypes when
injected alone or when co-injected at reduced levels as
described above for Neogenin (Table 2). Mosaic EGFP
expression generated by our RGMa-EGFP reporter constructs
was extinguished by both RGMa MOs, but not by the Std
Control MO or the Sema3-ATG MO (data not shown). These
results confirmed the efficiency and the specificity of the
RGMa knock down. As with the Neogenin experiments,
embryos injected with either the RGMa MOs or Std Control
MO exhibited no gross defects in morphology, forebrain
patterning or axon scaffold formation (blue staining, Fig. 6B).
However, knock down of RGMa produced the same statis-
tically significant axon guidance defects in the SOT as
observed with loss of Neogenin function (Table 2; Figs. 6A–
D). In 52% of brain hemispheres injected with RGM-ATG MO
(n = 100), NOC-2+ axons failed to completely project along the
SOT pathway, and we observed similar abnormalities in the
guidance of nPT axons in the dorsal forebrain (33%) to those
reported following loss of Neogenin (compare Fig. 6A with
Fig. 4H; and Fig. 6D with Fig. 4G)). These results suggested
that Neogenin was mediating its effect by interacting withFig. 7. Simultaneous partial knock down of Neogenin with either RGMa or Netrin-1 s
from stage 32 embryos, dorsal to the top, rostral to the left, immunolabeled for the NO
ATG MO (Part-Control), showing normal axon pathways. Embryos injected with
appearance. (B, C) Two examples of abnormal phenotypes seen in animals injected
RGMa. The SOT is reduced (B, unfilled arrowhead) or fails to form (C) and there are
(D, E) Two examples of abnormal phenotypes seen in animals injected with a com
Netrin-1. The SOT is reduced or fails to form correctly (D, filled arrowheads in pa
forebrain (arrow in panel E). (F) Animal injected with a combination of MOs to
Semaphorin3, showing normal axon pathways (compare the phenotype to panel ARGMa. Importantly, these findings also provide the first
evidence that RGMa plays an axon guidance role during in
vivo development.
Next, we examined the effect of knocking down Netrin-1, a
second putative ligand for Neogenin in the forebrain. Again, we
used two non-overlapping MOs against Netrin-1 (Net-ATGMO
and Net-UTR MO). As previously demonstrated for our other
MOs, mosaic EGFP expression generated by our Netrin-1-
EGFP reporter constructs was extinguished by both Netrin-1
MOs, but not by the Std Control MO or Sema3-ATG MO (data
not shown). Injection of each Netrin-1 MO alone, or co-
injection of the Net-ATG and Net-UTR MOs, produced similar
phenotypes without gross morphological defects, which con-
firmed the specificity of the knock down (Table 2). As with the
individual knock downs of Neogenin and RGMa, loss of Netrin-
1 caused statistically significant defects in the formation of the
SOT (Table 2; Figs. 6E, G, H). In brain hemispheres injected
with Netrin-ATG MO (n=72), ∼40% displayed SOT defects,
and ∼44% displayed abnormal pathfinding of nPT axons in the
dorsal forebrain. However, animals lacking Netrin-1 displayed
additional defects in the formation of the ventral commissure
that were absent from animals lacking Neogenin or RGMa.
Axons looped and failed to correctly grow through the ventral
commissure when Netrin-1 was knocked down (arrows, Figs.
6F and H). These results were consistent with the presence of
other Netrin-1 receptors, such as DCC, which we have
previously shown to be involved in midline crossing in the
ventral commissure (Anderson et al., 2000a).hows genetic interaction in vivo. All panels show lateral views of dissected brains
C-2+ subpopulation of axons. (A) Animal injected with a reduced dose of Neo-
a reduced dose of either RGM-ATG MO or Netrin-ATG MO had the same
with a combination of MOs to elicit partial knock down of both Neogenin and
abnormal caudoventrally directed nPT axons in the dorsal forebrain (B, arrows).
bination of MOs to elicit simultaneous partial knock downs of Neogenin and
nel E), and there are abnormal caudoventrally directed nPT axons in the dorsal
elicit simultaneous partial knock down of Neogenin and an unrelated ligand,
). Scale bar=30 μm.
Fig. 8. Proposed model for axon guidance in the supraoptic tract, mediated by
interactions between Neogenin, RGMa and Netrin-1. The Neogenin receptor is
expressed by a subset of neurons in the nPT (blue). Axons exiting the nPT are
funneled into the SOT via a wedge of the chemorepulsive ligand RGMa (red −),
expressed in a stripe of neuroepithelium lying ventral and rostral to the tract.
Axons are also simultaneously attracted ventrally by a chemoattractive gradient
of Netrin-1 expression underlying the TPOC (green +). When Neogenin, RGMa
or Netrin-1 are knocked down, the SOT fails to form correctly and nPT axons
follow abnormal trajectories.
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The above results suggested that Neogenin, RGMa and
Netrin-1 were essential for the correct formation of the SOT. To
test whether these molecules were functioning within a common
pathway during SOT development, we investigated potential
interactions among their gene products. Similar genetic
interaction studies using MO-based approaches have previously
been used in zebrafish to identify receptor-ligand pairs
(Cavodeassi et al., 2005). We predicted that if RGMa or
Netrin-1 were acting through Neogenin in the formation of the
SOT, then partial knock down of Neogenin would enhance
weak phenotypes generated by partial knock down of either
RGMa or Netrin-1. Therefore, the amount of each MO injected
was systematically decreased until the number of injected
hemispheres displaying abnormal phenotypes was no longer
statistically significant from controls (Fig. 7A). We then co-
injected combinations of the MOs at these reduced levels to
determine whether their effects were additive. This technique
mimics double heterozygote studies in Drosophila, where
genetic interactions suggest a functional ligand-receptor pair
(Kidd et al., 1998). Here, we found that combined partial knock
downs of either Neogenin and RGMa, or Neogenin and Netrin-
1 caused a statistically significantly increase in abnormalities in
the formation of the SOT (Table 3; Figs. 7B–E). As we showed
following the individual knock downs, NOC-2+ nPT axons
failed to correctly navigate the SOT pathway in ∼55% of brain
hemispheres co-injected with Neogenin and RGMa MOs
(n=92) and ∼52% of hemispheres co-injected with Neogenin
and Netrin-1 MOs (n=67). In contrast, combined partial knock
down of Neogenin with an unrelated ligand (Semaphorin 3;
n=33) did not increase the incidence of SOT abnormalities
(∼21%; Table 3; Fig. 7F). Taken together, these results areTable 3
Simultaneous partial knock downs of Neogenin with RGMa or Netrin-1 reveals
their interaction within a common axon guidance pathway
Injection regime a n b SOT reduced or
unformed (%)
Needle Stab Control 164 23.2 c
Part-Std Control MO 127 22.0
Part-Neo MO 126 31.7
Part-RGM MO 79 33.0
Part-Netrin MO 77 32.5
Part-Sema3 MO 37 24.3
Part-Neo+Part-RGM MOs 92 54.4*
Part-Neo+Part-Netrin MOs 67 52.3*
Part-Neo+Part-Sema3 MOs 33 21.2
*p<0.05; Chi-squared test of association. Phenotype numbers in the
simultaneous partial knock down groups were compared with single injections
of each MO alone.
a All groups except needle stab controls were co-injected with 2.3 ng of
EGFP mRNA per embryo to trace injected cells. For amounts of MOs injected,
see Materials and methods.
b n refers to the number of injected brain hemispheres examined (identified
by fluorescence of EGFP in all groups except needle stab controls).
c This value indicates a seemingly higher background of SOT defects in
animals in this series of experiments. However, there was no statistically
significant difference between the Needle Stab and Std Control MO groups
within each of these experiments.consistent with Neogenin, RGMa and Netrin-1 functioning
within a common signaling pathway during development of the
SOT (see proposed model, Fig. 8).
Discussion
In this study, we have shown for the first time that Neogenin
has an important and selective role in axon guidance during
vertebrate forebrain development, which is mediated specifi-
cally through its interactions with RGMa and Netrin-1. This
receptor and its ligands were involved in establishing the
supraoptic tract (SOT), the earliest dorsoventral pathway linking
the telencephalon with the diencephalon in the vertebrate fore-
brain. Although Neogenin has been shown to bind to RGMa and
Netrin-1 in vitro, we have been able to provide the first evidence
that these molecules interact in vivo to guide axons.
We showed that Neogenin was expressed by telencephalic
neurons that give rise to the SOT. The SOT of lower vertebrates
is the precursor of the internal capsule in mammals. Interest-
ingly in mice, Neogenin is also expressed in this pathway
(Braisted et al., 2000; Leighton et al., 2001), suggesting
conservation of function across species. When Neogenin
signaling was prevented, either by morpholino knock down or
expression of a truncated mutant version of Neogenin, nPT
axons failed to navigate their correct pathway within the SOT
and instead followed highly aberrant trajectories. Our results
also indicated that a signal mediated by Neogenin usually
prevents some nPT axons from exiting inappropriately in a
caudal direction and growing within the dorsal forebrain. Thus,
Neogenin appears to transduce an important guidance cue that
forces a subset of nPT axons to exit ventrally and grow within
the SOT.
To gain further insights into the guidance signal(s) being
mediated by Neogenin in the forebrain, we examined the effect
of knocking down two Neogenin ligands: RGMa and Netrin-1.
Whereas RGMa was recently reported to be present in Xenopus
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is selectively expressed in the forebrain by specific bands of
neuroepithelium that appear to flank many of the axon tracts.
RGMa expression is absent from the pathways underlying the
nPT, SOT and TPOC. Axons in these tracts grow adjacent to,
but not within, the zones of RGMa expression. nPT axons
entering the SOT pathway appear to turn and course caudo-
ventrally from their rostral projection upon encountering a
wedge of RGMa expression in the rostral forebrain. Taken
together, this expression pattern suggested that RGMa was
involved in contact-mediated repulsion and was consistent with
its role as a putative ligand for Neogenin during the formation of
the SOT. This idea was subsequently confirmed when we
knocked down RGMa and showed that the axon guidance
phenotype was similar to that observed following Neogenin
knock down. Consistent with previous in vitro reports
(Rajagopalan et al., 2004), RGMa expression in the vicinity
of the SOT appears to be essential for ensuring axons are
directed to grow ventrally into a region devoid of this ligand. It
appears that the expression of RGMa ventral to the dorsal
telencephalic neurons acts to funnel axons into the SOT.
RGMa has been implicated in a number of developmental
processes apart from axon guidance. For example, RGMa
knockout mice display defects in neural tube closure (Nieder-
kofler et al., 2004), and both RGMa and RGMb/DRAGON
have recently been identified as co-receptors for bone
morphogenetic protein (BMP), acting to enhance signaling in
response to BMP-2 and BMP-4 in vitro (Babitt et al., 2005;
Samad et al., 2005). However, we have no evidence to suggest
that RGMa acts in either of these pathways in the developing
Xenopus embryo. Our RGMa knock down embryos did not
display defects in cephalic neural tube closure, in comparison to
the severe exencephalic phenotype observed in∼50% of RGMa
mutant mice (Niederkofler et al., 2004). Additionally, we did
not observe dorsalization phenotypes (expanded brain forma-
tion, compromised trunk development) reported for Xenopus
embryos lacking BMP-2 and/or BMP-4 (Reversade et al.,
2005), suggesting that RGMa may not play a prominent role in
enhancing BMP signals in vivo. It is clear that Neogenin–
RGMa interactions are not affecting differentiation of neurons
because the NOC-2+ subpopulation of nPT neurons forms
normally in the absence of this receptor-ligand pair. It is
possible that some of the roles of RGMa may vary between
species because of differences in the expression of its ligands,
receptors and co-receptors. For example, RGMa knock out mice
display normal anterioposterior targeting of retinal ganglion
cells in the superior colliculus (Niederkofler et al., 2004),
despite the axon guidance role predicted for RGMa in the chick
retinotectal system (Monnier et al., 2002). However, in contrast
to the obvious gradient of RGMa expression that exists in the
chick optic tectum, RGMa is expressed uniformly in the
superior colliculus in mice. Nonetheless, loss of RGMa does
seem to have a consistent effect on the formation of structures in
the dorsal brain. The exencephalic RGMa mutant mice only
displayed defects in the morphogenesis of dorsal brain
structures, whereas the ventral brain, spinal cord and brainstem
were anatomically normal (Niederkofler et al., 2004). Similarlyin our RGMa knock down embryos, the guidance of axons
arising from a dorsal brain nucleus were selectively disrupted,
whereas the gross appearance and axon trajectories of the
ventral brain were unaffected.
We next examined the effect of knocking down Netrin-1, a
second putative ligand for Neogenin during axon scaffold
formation. Our reported expression pattern for Netrin-1 is
similar to that described by de la Torre and colleagues (1997).
Because Netrin-1 is a secreted protein (Kennedy et al., 1994), its
expression underlying the TPOC in the ventral CNS is
consistent with its role in the chemoattractive guidance of
nPT axons to form the SOT, as soluble ligands have been
demonstrated to act over such a distance (Gurdon and Bourillot,
2001). Indeed, we found that loss of Netrin-1 caused SOT
defects in the Xenopus forebrain. As observed following knock
down of either Neogenin or RGMa, axons from the nPT failed
to correctly form the SOT. Our results fit nicely with Netrin-1
providing an attractive axon guidance gradient to induce the
ventral growth of nPT axons into the SOT pathway. Such a role
is supported by previous reports of the chemoattractive activity
of Netrin-1 in vivo (Serafini et al., 1996). Furthermore, Netrin-1
has previously been shown to promote the growth of thala-
mocortical axons during the formation of the internal capsule in
mice (Braisted et al., 2000), suggesting conservation of function
across species. We cannot, however, rule out the alternative
possibility that Netrin-1 expression in the dorsal forebrain
contributes to SOT formation via a chemorepulsive mechanism.
In the spinal cord of mice, dorsally derived Netrin-1 has recently
been shown to provide an inhibitory cue, transduced by Unc-5c
receptors which form heterodimers with DCC (Hong et al.,
1999; Watanabe et al., 2006). In Xenopus, Unc-5 mRNA
expression has been reported in the dorsal forebrain (Anderson
and Holt, 2002) and may be expressed by neurons in the nPT.
Therefore, a chemorepulsive signal to Netrin-1 in the dorsal
forebrain may contribute to the initial guidance of nPT axons
ventrally into the SOT pathway. Further analysis of the
complement of Netrin-1 receptors in the nPT is required for
confirmation of this Netrin-1-mediated mechanism during SOT
formation.
We observed abnormal projection of nPT axons into the
dorsal forebrain following knock down of either Neogenin,
RGMa or Netrin-1. Although the mechanism underlying this
phenotype remains unclear, it is most likely that other guidance
cues are present that attract axons dorsocaudally in the absence
of these molecules. We favor a model whereby Neogenin-
expressing nPT axons are initially funneled into the SOT
pathway by the chemorepulsive activity of RGMa. These axons
are simultaneously attracted towards the ventral brain by an
increasing gradient of chemoattractive Netrin-1. Therefore, the
SOT may form by a concerted interplay of chemorepulsive and
chemoattractive cues, both mediated by Neogenin. The results
support the idea that a single axon guidance receptor may
mediate interactions with both chemorepulsive and chemo-
attractive ligands within the same axon pathway. This unique
ability of axons expressing Neogenin to simultaneously respond
to quite different ligands reveals their remarkable integrative
ability and highlights the principle that a combination of signals
497N.H. Wilson, B. Key / Developmental Biology 296 (2006) 485–498are needed to drive axons along specific routes within the
embryonic brain. It is interesting to note that we have previously
shown that the NOC-2+ SOT axons enter into the TPOC by
selectively fasciculating with other NOC-2+ axons already
present in this tract (Anderson and Key, 1999). We have also
previously demonstrated that the DCC, BOC (brother of CDO),
Roundabout and Neuropilin-1 receptors are involved in the
development of these tracts (Anderson et al., 2000a,b; Connor
and Key, 2002; Connor et al., 2005). Together, these studies
indicate that Neogenin, RGMa and Netrin-1 contribute to the
complement of guidance cues and cellular interactions that are
needed for the establishment of the earliest forming axon
pathways in the embryonic vertebrate forebrain.
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